NSCLC Coverage From Every Angle
Advertisement
Advertisement

Leora Horn, MD, on NSCLC: The Path Forward for ALK Inhibitors and Immunotherapy

Posted: Monday, June 11, 2018

Leora Horn, MD, of Vanderbilt University Medical Center, discusses combination regimens for non–small cell lung cancer as well as their multiple toxicities and how they can best be managed.



By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.